NCT01591850View on ClinicalTrials.gov

A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Healthy Volunteer

Interventions

DRUG

RO5093151

Single oral dose

DRUG

atazanavir

Multiple oral doses

DRUG

ketoconazole

Multiple oral doses

DRUG

rifampicin

Multiple oral doses

DRUG

ritonavir

Multiple oral doses

Trial Locations (1)

32953

Merritt Island

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01591850 - A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers | Biotech Hunter | Biotech Hunter